The long-term objective of this project is to determine the molecular mechanisms by which different MBD proteins target specific methylated DNA sequences to carry out distinct functional roles. In mammals, the MBD protein family consists of at least seven proteins involved in different aspects of normal and pathologic developmental gene silencing, DNA mismatch repair, and aberrant tumor suppressor gene silencing in carcinogenesis. In studying the molecular details of MBD2 bound to methylated DNA, we have shown that the protein can exchange rapidly between binding sites in the same DNA molecular. This observation led us to postulate that the distinct functional roles depend, at least in part, o dynamic and structural DNA binding characteristics of the particular MBD involved. Building on this observation, we plan to investigate the sequence dependent and independent binding of MBDs to DNA in the context of multiple target sites. In particular, we will focus on the structure and binding affinity of MBD2, MBD3, and MBD4. Although MBD2 and MBD3 are highly homologous, MBD2 binds with greater affinity and selectivity for methylated DNA. In contrast, MBD4 recognizes a G-T base pair mismatch arising from hydrolytic deamination of methyl-cytosine. The proposed work will involve NMR spectroscopy, surface plasmon resonance, isothermal titration calorimetry, and fluorescence anisotropy techniques. We will correlate the results of these biophysical and structural analyses with studies in tissue culture cells comparing the function of MBD2 mutants and domain swap chimeras. The latter studies will determine whether functional specificity of different MBD proteins reflects the DNA binding and structural properties of the MBD itself. These experiments will involve co-IP, ChIP, and gene expression studies in tissue culture cells. Ultimately, this work will provide unique insight into the mechanisms of DNA methylation dependent gene silencing and DNA mismatch repair.

Public Health Relevance

Studying the details of how protein complexes bind to DNA and regulate the expression of genes advances our ability to modify the expression of specific genes for therapeutic benefit. In these studies, we will examine the binding characteristics of a family of related proteins, the methyl-cytosine binding domain (MBD) proteins, which recognize methylated DNA and control expression of key genes during development and tumor suppressor genes in cancer. The results of these studies will resolve why different MBD proteins control expression of specific genes and provide a rational basis to design inhibitors of individua MBD proteins for therapy of human disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM098264-01A1
Application #
8294078
Study Section
Macromolecular Structure and Function C Study Section (MSFC)
Program Officer
Smith, Ward
Project Start
2012-05-01
Project End
2017-04-30
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
1
Fiscal Year
2012
Total Cost
$275,774
Indirect Cost
$85,774
Name
Virginia Commonwealth University
Department
Pathology
Type
Schools of Medicine
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Pan, Hai; Bilinovich, Stephanie M; Kaur, Parminder et al. (2017) CpG and methylation-dependent DNA binding and dynamics of the methylcytosine binding domain 2 protein at the single-molecule level. Nucleic Acids Res 45:9164-9177
Cramer, Jason M; Pohlmann, Deborah; Gomez, Fernando et al. (2017) Methylation specific targeting of a chromatin remodeling complex from sponges to humans. Sci Rep 7:40674
Sperlazza, M Jeannette; Bilinovich, Stephanie M; Sinanan, Leander M et al. (2017) Structural Basis of MeCP2 Distribution on Non-CpG Methylated and Hydroxymethylated DNA. J Mol Biol 429:1581-1594
Torrado, Mario; Low, Jason K K; Silva, Ana P G et al. (2017) Refinement of the subunit interaction network within the nucleosome remodelling and deacetylase (NuRD) complex. FEBS J 284:4216-4232
Desai, Megha A; Webb, Heather D; Sinanan, Leander M et al. (2015) An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex. Nucleic Acids Res 43:3100-13
Cramer, Jason M; Scarsdale, J Neel; Walavalkar, Ninad M et al. (2014) Probing the dynamic distribution of bound states for methylcytosine-binding domains on DNA. J Biol Chem 289:1294-302
Walavalkar, Ninad M; Cramer, Jason M; Buchwald, William A et al. (2014) Solution structure and intramolecular exchange of methyl-cytosine binding domain protein 4 (MBD4) on DNA suggests a mechanism to scan for mCpG/TpG mismatches. Nucleic Acids Res 42:11218-32
Amaya, Maria; Desai, Megha; Gnanapragasam, Merlin Nithya et al. (2013) Mi2?-mediated silencing of the fetal ?-globin gene in adult erythroid cells. Blood 121:3493-501
Walavalkar, Ninad M; Gordon, Nathaniel; Williams Jr, David C (2013) Unique features of the anti-parallel, heterodimeric coiled-coil interaction between methyl-cytosine binding domain 2 (MBD2) homologues and GATA zinc finger domain containing 2A (GATAD2A/p66?). J Biol Chem 288:3419-27